<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Mail.com: Chronic pain</title>
    <link>http://www.mail.com/subjects/357338-chronic-pain.html</link>
    <description>Mail.com - the best personalized free web-based Email</description>
    <language>en</language>
    <dc:language>en</dc:language>
    <image>
      <title>Mail.com: Chronic pain</title>
      <url>http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png</url>
      <link>http://www.mail.com/subjects/357338-chronic-pain.html</link>
    </image>
    <item>
      <title>Fearing abuse, FDA blocks generic OxyContin</title>
      <link>http://www.mail.com/scitech/health/2025284-fearing-abuse-fda-blocks-generic-oxycontin.html</link>
      <description>WASHINGTON (AP) — Federal health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse. 
                   The Food and Drug Administration said late Tuesday it would not approve any generic versions of OxyContin based on the original formulation because it "poses an ...</description>
      <pubDate>Wed, 17 Apr 2013 11:30:02 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/2025284-fearing-abuse-fda-blocks-generic-oxycontin.html</guid>
      <dc:date>2013-04-17T11:30:02Z</dc:date>
    </item>
  </channel>
</rss>

